Supernus Pharmaceuticals
SUPN
#4334
Rank
C$2.76 B
Marketcap
$50.09
Share price
-0.83%
Change (1 day)
34.25%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.07

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.10. In 2022 the company made an earnings per share (EPS) of $1.58 an increase over its 2021 EPS that were of $1.43.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.07-32.19%
2022$1.5810.78%
2021$1.43-57.68%
2020$3.3712.09%
2019$3.010.47%
2018$2.9989.38%
2017$1.58-38.59%
2016$2.57534.48%
2015$0.41-211.54%
2014-$0.36-91.1%
2013-$4.0839.46%
2012-$2.93-69.27%
2011-$9.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$27.02 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.59 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.55 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.16 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.70 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA